Characteristics and mechanism associated with drug conjugated inorganic nanoparticles

Recent progress in MoS2 nanostructures for biomedical applications: Experimental and computational approach

In the category of 2D materials, MoS2 a transition metal dichalcogenide, is a novel and intriguing class of materials with interesting physicochemical properties, explored in applications ranging from cutting-edge optoelectronic to the frontiers of biomedical and biotechnology. MoS2 nanostructures an alternative to heavy toxic metals exhibit biocompatibility, low toxicity and high stability, and high binding affinity to biomolecules. MoS2 nanostructures provide a lot of opportunities for the advancement of novel biosensing, nanodrug delivery system, electrochemical detection, bioimaging, and photothermal therapy. Much efforts have been made in recent years to improve their physiochemical properties by developing a better synthesis approach, surface functionalization, and biocompatibility for their safe use in the advancement of biomedical applications. The understanding of parameters involved during the development of nanostructures for their safe utilization in biomedical applications has been discussed. Computational studies are included in this article to understand better the properties of MoS2 and the mechanism involved in their interaction with biomolecules. As a result, we anticipate that this combined experimental and computational studies of MoS2 will inspire the development of nanostructures with smart drug delivery systems, and add value to the understanding of two-dimensional smart nano-carriers.

Application of nanomaterials in diagnosis and treatment of glioblastoma

Diagnosing and treating glioblastoma patients is currently hindered by several obstacles, such as tumor heterogeneity, the blood-brain barrier, tumor complexity, drug efflux pumps, and tumor immune escape mechanisms. Combining multiple methods can increase benefits against these challenges. For example, nanomaterials can improve the curative effect of glioblastoma treatments, and the synergistic combination of different drugs can markedly reduce their side effects. In this review, we discuss the progression and main issues regarding glioblastoma diagnosis and treatment, the classification of nanomaterials, and the delivery mechanisms of nanomedicines. We also examine tumor targeting and promising nano-diagnosis or treatment principles based on nanomedicine. We also summarize the progress made on the advanced application of combined nanomaterial-based diagnosis and treatment tools and discuss their clinical prospects. This review aims to provide a better understanding of nano-drug combinations, nano-diagnosis, and treatment options for glioblastoma, as well as insights for developing new tools.

Multifunctional Gold Nanoparticles in Cancer Diagnosis and Treatment

Cancer is the second leading cause of death in the world, behind only cardiovascular diseases, and is one of the most serious diseases threatening human health nowadays. Cancer patients’ lives are being extended by the use of contemporary medical technologies, such as surgery, radiotherapy, and chemotherapy. However, these treatments are not always effective in extending cancer patients’ lives. Simultaneously, these approaches are often accompanied with a series of negative consequences, such as the occurrence of adverse effects and an increased risk of relapse. As a result, the development of a novel cancer-eradication strategy is still required. The emergence of nanomedicine as a promising technology brings a new avenue for the circumvention of limitations of conventional cancer therapies. Gold nanoparticles (AuNPs), in particular, have garnered extensive attention due to their many specific advantages, including customizable size and shape, multiple and useful physicochemical properties, and ease of functionalization. Based on these characteristics, many therapeutic and diagnostic applications of AuNPs have been exploited, particularly for malignant tumors, such as drug and nucleic acid delivery, photodynamic therapy, photothermal therapy, and X-ray-based computed tomography imaging. To leverage the potential of AuNPs, these applications demand a comprehensive and in-depth overview. As a result, we discussed current achievements in AuNPs in anticancer applications in a more methodical manner in this review. Also addressed in depth are the present status of clinical trials, as well as the difficulties that may be encountered when translating some basic findings into the clinic, in order to serve as a reference for future studies.

Effect of dopant concentration and the role of ZnS shell on optical properties of Sm3+ doped CdS quantum dots

The role of samarium (Sm) dopant on the structural, morphological, and optical properties of CdS QDs and CdS/ZnS core/shell QDs was methodically reported. The synthesis of Sm-doped CdS QDs and CdS/ZnS QDs was carried out via a facile wet chemical method. The structure, chemical composition, and optical properties of the synthesized QDs were investigated by using X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), Raman spectroscopy (RS), and photoluminescence (PL) spectroscopy. XRD analysis showed that the synthesized CdS QDs exhibited zinc blende structure which was not affected by doping Sm3+ ions. The particle size of the CdS:Sm and CdS:Sm (2%)/ZnS QDs was estimated to be ∼4 nm and ∼7 nm, respectively. Transmission electron microscopy (TEM) images revealed that the incorporation of Sm dopant did not significantly affect the size and morphology of CdS QDs, while the formation of the ZnS shell increased the particle size. XPS and XRD results confirmed the successful incorporation of Sm3+ ions into the CdS QDs. The effect of dopant concentration on the structural and luminescent properties was studied. The emission and excitation spectra of Sm3+-doped CdS QDs and CdS/ZnS QDs consisted of the characteristic lines corresponding to the intra-configurational f-f transitions. The energy transfer (ET) mechanism from the host to Sm3+ ions and the ET process through cross-relaxation between Sm3+ ions have been elucidated. The effect of the ZnS shell on the optical stability of the Sm3+-doped CdS QDs was studied in detail and the results showed that the CdS:Sm (2%)/ZnS QDs retained their good emission characteristics after 376 days of fabrication. The luminescent properties of Sm-doped QDs ranging from violet to red and PL lifetime extending to milliseconds demonstrated that these QDs are the potential materials for applications in white LEDs, biomarkers, and photocatalysis.